Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
Jenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2016
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle
Erik P Rader, Rolf Turk, Tobias Willer, et al.
BMC Genomics
|
August 20, 2004
Gene expression variation between mouse inbred strains
Rolf Turk, Peter A C 't Hoen, Ellen Sterrenburg, et al.
Neurobiology of Disease
|
May 9, 2006
Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4
Ellen Sterrenburg, Caroline G C van der Wees, Stefan J White, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
A guide RNA repeat checkpoint steers CRISPR-Cas9 catalysis
Ramadevi Chilamkurthy, Sruthi Sudhakar, Adrian A Pater, et al.
Molecular Therapy. Methods & Clinical Development
|
May 13, 2021
CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing
Gavin Kurgan, Rolf Turk, Heng Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 29, 2010
Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain
Jakob S Satz, Adam P Ostendorf, Shangwei Hou, et al.
Methods (San Diego, Calif.)
|
March 30, 2017
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes
Ashley M Jacobi, Garrett R Rettig, Rolf Turk, et al.
Pharmacogenomics
|
April 14, 2006
Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy
Peter A C 't Hoen, Caroline G C van der Wees, Annemieke Aartsma-Rus, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 23, 2009
Visual impairment in the absence of dystroglycan
Jakob S Satz, Alisdair R Philp, Huy Nguyen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
Jenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2016
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle
Erik P Rader, Rolf Turk, Tobias Willer, et al.
BMC Genomics
|
August 20, 2004
Gene expression variation between mouse inbred strains
Rolf Turk, Peter A C 't Hoen, Ellen Sterrenburg, et al.
Neurobiology of Disease
|
May 9, 2006
Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4
Ellen Sterrenburg, Caroline G C van der Wees, Stefan J White, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
A guide RNA repeat checkpoint steers CRISPR-Cas9 catalysis
Ramadevi Chilamkurthy, Sruthi Sudhakar, Adrian A Pater, et al.
Molecular Therapy. Methods & Clinical Development
|
May 13, 2021
CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing
Gavin Kurgan, Rolf Turk, Heng Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 29, 2010
Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain
Jakob S Satz, Adam P Ostendorf, Shangwei Hou, et al.
Methods (San Diego, Calif.)
|
March 30, 2017
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes
Ashley M Jacobi, Garrett R Rettig, Rolf Turk, et al.
Pharmacogenomics
|
April 14, 2006
Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy
Peter A C 't Hoen, Caroline G C van der Wees, Annemieke Aartsma-Rus, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 23, 2009
Visual impairment in the absence of dystroglycan
Jakob S Satz, Alisdair R Philp, Huy Nguyen, et al.
Page
of 3